Northwestern Mutual Investment Management Company’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.19M | Sell |
4,052
-21
| -0.5% | -$5.96K | 0.01% | 544 |
|
|
2026
Q1 | $1.14M | Buy |
4,073
+4
| +0.1% | +$1.15K | 0.02% | 528 |
|
|
2025
Q4 | $1.23M | Hold |
4,069
| – | – | 0.01% | 495 |
|
|
2025
Q3 | $1.14M | Sell |
4,069
-84
| -2% | -$22.9K | 0.02% | 526 |
|
|
2025
Q2 | $1M | Sell |
4,153
-131
| -3% | -$31K | 0.02% | 555 |
|
|
2025
Q1 | $1.04M | Buy |
4,284
+5
| +0.1% | +$1.5K | 0.02% | 522 |
|
|
2024
Q4 | $1.41M | Buy |
4,279
+31
| +0.7% | +$10.5K | 0.03% | 407 |
|
|
2024
Q3 | $1.42M | Buy |
4,248
+3,598
| +554% | +$1.14M | 0.03% | 403 |
|
|
2024
Q2 | $178K | Sell |
650
-14
| -2% | -$4.07K | ﹤0.01% | 873 |
|
|
2024
Q1 | $230K | Buy |
664
+1
| +0.2% | +$329 | 0.01% | 870 |
|
|
2023
Q4 | $214K | Buy |
663
+4
| +0.6% | +$1.25K | 0.01% | 871 |
|
|
2023
Q3 | $236K | Sell |
659
-15
| -2% | -$5.79K | 0.01% | 859 |
|
|
2023
Q2 | $256K | Sell |
674
-2
| -0.3% | -$814 | 0.01% | 860 |
|
|
2023
Q1 | $324K | Buy |
676
+1
| +0.1% | +$468 | 0.01% | 827 |
|
|
2022
Q4 | $284K | Sell |
675
-121
| -15% | -$48.8K | 0.01% | 758 |
|
|
2022
Q3 | $332K | Sell |
796
-70
| -8% | -$34.9K | 0.01% | 791 |
|
|
2022
Q2 | $429K | Buy |
866
+7
| +0.8% | +$3.65K | 0.01% | 769 |
|
|
2022
Q1 | $484K | Sell |
859
-113
| -12% | -$68.1K | 0.01% | 791 |
|
|
2021
Q4 | $734K | Sell |
972
-4
| -0.4% | -$2.99K | 0.01% | 667 |
|
|
2021
Q3 | $728K | Sell |
976
-4
| -0.4% | -$3K | 0.01% | 643 |
|
|
2021
Q2 | $631K | Buy |
980
+4
| +0.4% | +$2.43K | 0.01% | 704 |
|
|
2021
Q1 | $557K | Sell |
976
-205
| -17% | -$121K | 0.01% | 745 |
|
|
2020
Q4 | $688K | Buy |
1,181
+6
| +0.5% | +$3.42K | 0.01% | 773 |
|
|
2020
Q3 | $531K | Hold |
1,175
| – | – | 0.01% | 779 |
|
|
2020
Q2 | $531K | Sell |
1,175
-6,327
| -84% | -$2.79M | 0.01% | 781 |
|
|
2020
Q1 | $2.63M | Buy |
7,502
+1,331
| +22% | +$489K | 0.04% | 154 |
|
|
2019
Q4 | $2.28M | Buy |
6,171
+42
| +0.7% | +$14.8K | 0.04% | 187 |
|
|
2019
Q3 | $2.04M | Buy |
6,129
+415
| +7% | +$135K | 0.04% | 192 |
|
|
2019
Q2 | $1.79M | Buy |
5,714
+2,132
| +60% | +$638K | 0.04% | 231 |
|
|
2019
Q1 | $1.09M | Sell |
3,582
-224
| -6% | -$60.4K | 0.02% | 550 |
|
|
2018
Q4 | $884K | Buy |
3,806
+30
| +0.8% | +$8.05K | 0.01% | 591 |
|
|
2018
Q3 | $1.18M | Sell |
3,776
-205
| -5% | -$63.6K | 0.02% | 573 |
|
|
2018
Q2 | $1.15M | Sell |
3,981
-155
| -4% | -$42.8K | 0.02% | 589 |
|
|
2018
Q1 | $1.03M | Buy |
4,136
+1,489
| +56% | +$379K | 0.02% | 631 |
|
|
2017
Q4 | $632K | Buy |
2,647
+16
| +0.6% | +$3.88K | 0.01% | 639 |
|
|
2017
Q3 | $585K | Sell |
2,631
-952
| -27% | -$214K | 0.01% | 650 |
|
|
2017
Q2 | $811K | Hold |
3,583
| – | – | 0.01% | 630 |
|
|
2017
Q1 | $714K | Buy |
3,583
+6
| +0.2% | +$1.16K | 0.01% | 665 |
|
|
2016
Q4 | $652K | Buy |
3,577
+20
| +0.6% | +$3.41K | 0.01% | 658 |
|
|
2016
Q3 | $583K | Sell |
3,557
-39
| -1% | -$5.92K | 0.01% | 665 |
|
|
2016
Q2 | $514K | Hold |
3,596
| – | – | 0.01% | 543 |
|
|
2016
Q1 | $492K | Buy |
+3,596
| New | +$472K | 0.01% | 568 |
|
Other funds holding BIO
GKIM
Northwestern Mutual Investment Management Company's BIO Position: Q2 2026 in Review
Northwestern Mutual Investment Management Company reduced its Bio-Rad Laboratories Class A (BIO) stake by 0.52% in Q2 2026, selling an estimated $5.96K and leaving 4,052 shares worth $1.19M. The position accounts for 0.01% of the portfolio, ranked #544.
Northwestern Mutual Investment Management Company first reported a position in BIO in Q1 2016 and has held it in 42 quarters since. The position peaked at $2.63M in Q1 2020. 252 funds tracked by Wall St. Rank hold BIO as of Q2 2026.
- Northwestern Mutual Investment Management Company held 4,052 shares of Bio-Rad Laboratories Class A worth $1.19M as of Q2 2026.
- Northwestern Mutual Investment Management Company sold 21 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $5.96K.
- Bio-Rad Laboratories Class A made up 0.01% of Northwestern Mutual Investment Management Company's portfolio in Q2 2026, its #544 holding.
- Northwestern Mutual Investment Management Company first reported a position in Bio-Rad Laboratories Class A in Q1 2016 and has held it in 42 quarters since.
- Northwestern Mutual Investment Management Company's Bio-Rad Laboratories Class A position peaked at $2.63M in Q1 2020.
- 252 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.
Based on Northwestern Mutual Investment Management Company's 13F filing for Q2 2026, filed 12 Aug 2026.